Meta-analysis of Randomized Controlled Trials Assessing the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies on Mortality and Cardiovascular Outcomes.
Am J Cardiol
; 124(12): 1869-1875, 2019 12 15.
Article
in En
| MEDLINE
| ID: mdl-31679643
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Coronary Disease
/
Antibodies, Monoclonal, Humanized
/
Proprotein Convertase 9
/
Myocardial Infarction
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
/
Systematic_reviews
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Am J Cardiol
Year:
2019
Document type:
Article
Affiliation country:
Canada
Country of publication:
United States